Related Experiment Video
Updated: Aug 2, 2025

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
Published on: April 21, 2022
Systemic vasculitis: one year in review 2023
Michele Moretti1, Elena Treppo2, Sara Monti3
1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Insights
Systemic vasculitis involves chronic blood vessel inflammation. This review covers recent COVID-19 impacts, new treatments, and precision medicine approaches for small- and large-vessel vasculitis.
Area of Science:
- Rheumatology and Immunology
- Internal Medicine
- Vascular Biology
Background:
- Systemic vasculitides are chronic inflammatory diseases of blood vessels.
- These conditions can lead to significant tissue damage and organ failure.
- The COVID-19 pandemic has influenced vasculitis epidemiology and patient management.
Purpose of the Study:
- To critically review recent literature on systemic vasculitis.
- To focus on advancements in pathophysiology, diagnosis, and treatment.
- To highlight the role of precision medicine in managing small- and large-vessel vasculitis.
Main Methods:
- Comprehensive literature search of recent publications.
- Critical analysis of studies on vasculitis pathophysiology and clinical aspects.
- Review of emerging diagnostic tools and therapeutic strategies.
Main Results:
- New insights into the pathogenesis of systemic vasculitis.
- Identification of potential novel therapeutic targets.
- Evaluation of newer glucocorticoid-sparing treatments with improved safety profiles.
- Impact of COVID-19 on vasculitis patient care and disease patterns.
Conclusions:
- Recent advancements offer improved understanding and management of systemic vasculitis.
- Precision medicine holds promise for tailored treatment strategies.
- Continued research is essential for optimizing patient outcomes in vasculitis.
Abstract:
Systemic vasculitides are heterogeneous disabling diseases characterised by chronic inflammation of the blood vessels potentially leading to tissue destruction and organ failure. The recent COVID-19 pandemic has had a significant impact on the epidemiology and management of patients with systemic vasculitis. In parallel, new insights have been provided on systemic vasculitis pathogenetic mechanisms, possible new therapeutic targets, and newer glucocorticoid-sparing treatments with better safety profiles. As in the previous annual reviews of this series, in this review we will provide a critical digest of the most recent literature regarding pathophysiology, clinical manifestations, diagnostic tools and treatment options in small- and large-vessel vasculitis focusing on precision medicine in vasculitis.
Related Concept Videos
Overview of Systemic Arteries
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
Endocarditis I: Introduction
Myocarditis I: Introduction
Overview of Systemic Veins
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
Nephrotic Syndrome I : Introduction
Pericarditis I: Introduction

